The global decrease in cancer mortality: trends and disparities
D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri, D Hashim, P Boffetta, C La Vecchia, M Rota, P Bertuccio, M Malvezzi, E Negri
Abstract
Background: A decrease in cancer mortality has been reported in the United States, Europe, and other high-income regions during the last two decades. Whether similar trends apply to low-to-middle income countries-and globally-is unclear.
Design: The aim of this descriptive study is to compare cancer mortality in all countries with high- or intermediate-quality data on death certificates according to the World Health Organization (WHO) mortality database for the years 2000 through 2010. We included 60 countries in the analysis and calculated age-adjusted mortality rates for all cancer combined and for the commonest cancers worldwide: lung, stomach, breast, colorectal, uterine, and prostate.
Results: A decrease in overall cancer mortality rate of ∼1% per year was observed in higher and lower income regions and in both sexes. In 2010, 696 000 cancer deaths were avoided on a global scale compared with 2000 rates (426 000 in men, 271 000 in women). However, the mortality of liver cancer in both sexes and lung cancer in females increased in many countries'.
Conclusions: The individual risk of dying from cancer decreased in all countries with reliable data. This decrease was chiefly due to favorable trends in the commonest specific cancers. Liver cancer in both sexes and lung cancer in women, which show increasing mortality rates, constitute a priority for prevention and further research.
Keywords: cancer; data collection/standards; global health; mortality; registries/standards; vital statistics.
© The Author 2016. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Source: PubMed
Közelgő klinikai vizsgálatok
-
University of TennesseeWoodcock Institute for the Advancement of Neurocognitive Research and Applied...Még nincs toborzásMotoros készségek | Egészséges | Végrehajtó funkció
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLCMég nincs toborzásAnális laphámsejtes karcinóma
-
Universita di VeronaAzienda Ospedaliera Universitaria Integrata VeronaMég nincs toborzásRheumatoid arthritis | Degeneratív térdízületi betegségOlaszország
-
University of Wisconsin, MadisonAlkermes, Inc.Még nincs toborzás
-
Virginia Commonwealth UniversityMég nincs toborzás
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH); Icahn School of Medicine at Mount SinaiMég nincs toborzásKetamin | fMRI | Depresszió – súlyos depressziós rendellenesség | rTMS | Kezelés-rezisztens depresszió (TRD)Egyesült Államok
-
Weill Medical College of Cornell UniversityBD2 LLCMég nincs toborzásfMRI | Bipoláris zavar (BD) | rTMS | Bipoláris 1 depresszióEgyesült Államok
-
Xentria, Inc.Még nincs toborzás
-
Yale UniversityNational Institute of Mental Health (NIMH)Még nincs toborzás
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeToborzásPheochromocytoma | Pheochromocytoma/Paraganglioma | Pheochromocytoma, metasztatikus | Pheochromocytoma Rosszindulatú | Feochromocytoma és paraganglioma (PPGL)Egyesült Királyság
-
Carl Zeiss Meditec-Dublin CoCeToborzásEpiretinális membrán | Retina betegség | Száraz életkorral összefüggő makuladegeneráció | Vitreoretinális rendellenesség | Macular Abnormalities | Intraretinal Hyporeflective Space | Subretinal Hyporeflective Space | IS/OS (Ellipsoid Zone) Disruption | Retinal Pigment Epithelium (RPE) Elevation | Retinal...Egyesült Államok
-
Celest Therapeutics (Shanghai) Co., Ltd.The First Affiliated Hospital of Anhui Medical UniversityToborzásCLDN18.2 pozitív szilárd daganatokKína